Yarrow Bioscience annual depreciation and amortization
2018
2019
2020
2021
2022
2023
2024
2025
Yarrow Bioscience Depreciation & Amortization Growth & History (YARW)
Yarrow Bioscience's depreciation and amortization was $23,000 for fiscal 2025.
View full Yarrow Bioscience company overviewYarrow Bioscience annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $23,000 | $19,000 | +475.00% |
| 2024 | 2024-12-31 | $4,000 | $4,000 | — |
| 2023 | 2023-12-31 | $0 | −$72,000 | — |
| 2022 | 2022-12-31 | $72,000 | −$37,000 | −33.94% |
| 2021 | 2021-12-31 | $109,000 | −$232,000 | −68.04% |
| 2020 | 2020-12-31 | $341,000 | −$9,000 | −2.57% |
| 2019 | 2019-12-31 | $350,000 | $31,000 | +9.72% |
| 2018 | 2018-12-31 | $319,000 | — | — |
Yarrow Bioscience quarterly depreciation and amortization
Q1.19
Q2.19
Q3.19
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q1.25
Q2.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $6,000 | $0 | 0.00% |
| Q1 2026 | 2026-03-31 | $6,000 | $0 | 0.00% |
| Q2 2025 | 2025-06-30 | $6,000 | $6,000 | — |
| Q1 2025 | 2025-03-31 | $6,000 | $6,000 | — |
| Q2 2024 | 2024-06-30 | $0 | $0 | — |
| Q1 2024 | 2024-03-31 | $0 | $0 | — |
| Q3 2023 | 2023-09-30 | $0 | −$171,000 | — |
| Q2 2023 | 2023-06-30 | $0 | −$12,000 | — |
| Q1 2023 | 2023-03-31 | $0 | −$44,000 | — |
| Q3 2022 | 2022-09-30 | $171,000 | $143,000 | +510.71% |
| Q2 2022 | 2022-06-30 | $12,000 | −$16,000 | −57.14% |
| Q1 2022 | 2022-03-31 | $44,000 | $17,000 | +62.96% |
| Q3 2021 | 2021-09-30 | $28,000 | −$39,000 | −58.21% |
| Q2 2021 | 2021-06-30 | $28,000 | −$66,000 | −70.21% |
| Q1 2021 | 2021-03-31 | $27,000 | −$66,000 | −70.97% |
| Q3 2020 | 2020-09-30 | $67,000 | −$26,000 | −27.96% |
| Q2 2020 | 2020-06-30 | $94,000 | $7,000 | +8.05% |
| Q1 2020 | 2020-03-31 | $93,000 | $17,000 | +22.37% |
| Q3 2019 | 2019-09-30 | $93,000 | — | — |
| Q2 2019 | 2019-06-30 | $87,000 | — | — |
| Q1 2019 | 2019-03-31 | $76,000 | — | — |
Yarrow Bioscience depreciation and amortization trends
Over the last five fiscal years, Yarrow Bioscience's depreciation and amortization decreased from $341,000 to $23,000, a change of −$318,000. The latest reported quarter, Q2 2026, shows $6,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Yarrow Bioscience source filings ↗